Description
Growth Hormone Research Peptides
Lyophilised powder
CJC-1295 + Ipamorelin is a dual-peptide blend containing 5mg of CJC-1295 and 5mg of Ipamorelin per vial (10mg total). It is prepared for in-vitro research investigating growth hormone secretagogue receptor signalling and peptide synergy models.
Published experimental literature has examined CJC-1295 in relation to GHRH receptor activity and Ipamorelin as a selective ghrelin receptor agonist. Combined protocols are frequently studied for receptor-pathway interaction and time-course response characteristics in laboratory settings.
This product is supplied in a sealed glass vial and is intended exclusively for use in controlled laboratory settings by qualified researchers.
Product Specifications
| Compound | CJC-1295 + Ipamorelin blend |
| Quantity | 10mg total per vial (CJC-1295 5mg + Ipamorelin 5mg) |
| Form | Lyophilised powder |
| Purity | ?98% (component peptides verified by third-party HPLC analysis) |
| Appearance | White to off-white lyophilised powder |
Storage Instructions
After reconstitution: Store at 2–8°C and minimise repeated freeze-thaw cycles.



